Resources
About Us
Home Report
Store
Europe DTC Laboratory Testing Market
Europe DTC Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, Thyroid, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood) - Forecast to 2030
Report ID:MRHC - 104958 Pages: 160 Jul-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 HoursThe Europe DTC Laboratory Testing Market is projected to reach $1.59 billion by 2030, at a CAGR of 10.8% from 2024 to 2030. Direct-to-consumer, DTC tests, or at-home genetic tests, are medical or genetic tests that consumers can order and perform at home without the involvement of a healthcare professional. These tests have become increasingly popular in recent years due to advancements in genetic testing technology and increased consumer interest in understanding their genetic makeup. The sample collected from the consumer is processed at a laboratory, and the results are sent directly to the consumer.
The growth of the Europe direct-to-consumer laboratory testing market is driven by several factors, including the rising incidence of chronic diseases & sexually transmitted diseases, high disposable income, increased consumer awareness, increasing awareness about personal health management, benefits of DTC laboratory testing such as high convenience, affordability, and accessibility, increasing prevalence of chronic and infectious diseases, increasing cost of healthcare, increasing consumer awareness about ancestry/genealogy testing, and the rising elderly population.
Factors such as the growing adoption of telehealth, expansion in emerging economies, and increasing penetration of pharmacogenomic testing in DTC laboratory testing are some opportunities that would help grow the market. Genetic data privacy concerns, misinterpretation of test results, and lack of professional medical counseling could be challenges for the Europe direct-to-consumer laboratory testing market. However, sample integrity and interference issues, regulatory concerns, lack of reimbursement, and the limited test portfolio compared to conventional laboratory testing restrain the market's growth.
Click here to: Get Free Sample Pages of this Report
Ease of Accessibility to DTC Tests and Effective Marketing to Consumers Drives Market Growth
Over the last few years, consumers have been actively participating in decisions affecting their health, enabling people to be informed of their health and lead healthy lifestyles. Clinical laboratory testing is an important part of healthcare. These tests can be ordered online or bought from pharmacies without any prescription, making them easy to access for consumers. The easy accessibility and convenience of ordering the tests online also attract customers.
Companies operating in this market are conducting marketing campaigns and advertisements to interest consumers and inform them about the benefits of DTC tests. This encourages customers to order these tests without needing to consult a physician. By using these DTC tests, consumers can get personalized information about their health, disease risk, and other traits and gain awareness of their genetic predisposition to illnesses. Thus, ease of accessibility to DTC tests and effective marketing to consumers.
Rising Prevalence of Chronic, Infectious, & Sexually Transmitted Diseases
The rising prevalence of chronic & infectious diseases is expected to drive the demand for DTC laboratory testing. Many DTC laboratory testing companies are offering tests for diagnosing infectious diseases and monitoring chronic diseases. In the case of sexually transmitted diseases (STDs), there has been a stigma surrounding it, leading to people not approaching healthcare providers for STD testing. Direct-to-consumer laboratory testing solves this problem by offering discretion and confidentiality to consumers. According to the European Centre for Disease Prevention and Control (ECDC), it is estimated that every year, over 500,000 sexually transmitted infections (STIs) are notified in the U.K. Thus, the advantages of DTC lab testing, such as discretion & confidentiality and the increased prevalence of sexually transmitted diseases, are expected to drive the demand for DTC lab testing.
Key Findings of the Europe DTC Laboratory Testing Market Study:
The Genetic Testing Segment is Expected to Account for the Largest Share of the Market in 2024
Among all the applications, in 2024, the genetic testing segment is expected to account for the largest share of the market. DTC genetic tests are those that are provided directly to consumers without involving a healthcare provider. This testing generally offers a wide range of genetic tests that can be helpful to provide consumers with information about their ancestry, health risks, and traits. This segment is driven by factors such as increasing awareness regarding personal health management, high curiosity about self-ancestry, strong marketing strategies by the companies, rising prevalence of various genetic & chronic diseases, and high demand for personalized testing services.
The Blood Segment is Expected to Account for the Largest Share of the Market in 2024
Among sample types, in 2024, the blood segment is expected to account for the largest share of the market. The blood sample is collected from consumers to test conditions such as diabetes, routine clinical testing, thyroid function, and sexually transmitted disease testing, among others, in order to gain insight into how the organs are functioning. Blood samples are collected using a lancet or a needle that is present in the kit provided to carry out the test. This segment is driven by factors such as a large variety of available tests using blood samples. Increasing prevalence of various chronic diseases and increasing consumer awareness regarding the monitoring of chronic diseases.
Key Players
The key players profiled in the Europe direct-to-consumer laboratory testing market report are LetsGetChecked, Inc. (U.S.), Laboratoire CERBA (France), 23andMe Holding Co. (U.S.), Medichecks.com Ltd. (U.K.), Cerascreen Biotech LLC (U.K.), Living DNA Ltd (U.K.), SelfDiagnostics Deutschland GmbH (Germany), SYNLAB International GmbH (Germany), Natrix S.r.l. (Italy), and Mainz Biomed Germany GmbH (Germany).
The report includes a competitive landscape based on an extensive assessment of the market based on application, sample type, and geography. The report also provides insights into the geographic presence of major market players and their key growth strategies in the last three to four years.
Scope of the Report:
Europe DTC Laboratory Testing Market, by Application
- Genetic Testing
- Ancestry/Genealogy
- Disease Risk Assessment
- Cancer
- Cardiovascular Diseases
- Neurological Diseases
- Other Diseases
(Note:Disease risk assessment testing for other diseases includes celiac disease, alpha-1 antitrypsin deficiency, factor XI deficiency, glucose-6-phosphate dehydrogenase deficiency etc.)
- Carrier Status
- Other Genetic Tests
(Note:Other genetic tests primarily include direct-to-consumer genetic testing for pharmacogenomics, skin care DNA tests, and nutrigenomic testing)
- Diabetes Testing
- Routine Clinical Testing
- Thyroid Function Testing
- Sexually Transmitted Disease Testing
- Other Applications
(Note:Other applications primarily include drug screening, infectious disease testing [Tuberculosis, Chicken pox, Measles, Mumps, Rubella, COVID, UTI], allergy testing, fertility, pregnancy, and nutritional testing.)
Europe DTC Laboratory Testing Market, by Sample Type
- Blood
- Saliva
- Urine
- Other Samples
(Note:Other samples primarily include stool, nasopharyngeal swab, vaginal swab, buccal swab, and semen.)
Europe DTC Laboratory Testing Market, by Country
- U.K.
- Germany
- France
- Spain
- Italy
- Switzerland
- Netherlands
- Belgium
- Denmark
- Ireland
- Rest of Europe (RoE)
Key questions answered in the report:
This market study covers the market sizes & forecasts of the direct-to-consumer (DTC) laboratory testing market in Europe based on application, sample type, and geography. This market study also provides the value analysis of various segments and subsegments of the Europe direct-to-consumer laboratory testing market at country levels.
The Europe DTC laboratory testing market is projected to reach $1.59 billion by 2030, at a CAGR of 10.8% during the forecast period.
The genetic testing segment is expected to account for the largest share of the market in 2024. Factors such as the rising appeal of DTC genetic testing to explore information regarding family health history and disease risk assessment testing, the launch of new DTC genetic tests for new applications and increasing curiosity among people in developed countries regarding their ancestry and lineage.
The blood segment is expected to account for the largest share in the Europe DTC laboratory testing market. The growth of this segment is attributed to the benefits of blood samples, such as the high reliability of results, the wide range of test options available, and the convenience of at-home blood collection service.
The growth of the Europe DTC laboratory testing market is driven by several factors, including the increased awareness about personal health management, benefits of DTC laboratory testing, such as high convenience, affordability, & accessibility, increasing prevalence of chronic & infectious diseases, increasing cost of healthcare, increasing consumer awareness about ancestry/genealogy testing, and the rising elderly population.
Furthermore, growing adoption of telehealth, expansion in emerging economies, and increasing penetration of pharmacogenomic testing in DTC laboratory testing serve as major opportunities for the existing market players and new entrants in the Europe DTC laboratory testing market.
The key players profiled in the Europe DTC laboratory testing market report are LetsGetChecked, Inc. (U.S.), Laboratoire CERBA (France), 23andMe Holding Co. (U.S.), Medichecks.com Ltd. (U.K.), Cerascreen Biotech LLC (U.K.), Living DNA Ltd (U.K.), SelfDiagnostics Deutschland GmbH (Germany), SYNLAB International GmbH (Germany), Natrix S.r.l. (Italy), and Mainz Biomed Germany GmbH (Germany).
Countries such as the U.K. and Germany are projected to offer significant growth opportunities for vendors operating in this market. This growth is mainly due to increased consumer awareness, high disposable income in the countries, rising incidence of chronic and sexually transmitted diseases, and favorable consumer behaviors in both countries.
1. Market Definition & Scope
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumption for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increased Awareness About Personal Health Management
4.2.2. Benefits of DTC Laboratory Testing such as High Convenience, Affordability & Accessibility
4.2.3 Increasing Prevalence of Chronic & Infectious Diseases
4.2.4. Increasing Cost of Healthcare
4.2.5. Increasing Consumer Awareness about Ancestry/Genealogy Testing
4.2.6. Rising Elderly Population
4.3. Restraints
4.3.1. Sample Integrity and Interference Issues
4.3.2. Regulatory Concerns
4.3.3. Lack of Reimbursement
4.3.4. Limited Test Portfolio Compared to Conventional Laboratory Testing
4.4. Opportunities
4.4.1. Growing Adoption of Telehealth
4.4.2. Expansion in Emerging Economies
4.4.3. Increasing Penetration of Pharmacogenomic Testing in DTC Laboratory Testing
4.5. Challenges
4.5.1. Genetic Data Privacy Concerns
4.5.2. Misinterpretation of Test Results
4.5.3. Lack of Professional Medical Counselling
4.6. Industry & Technological Trends
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Adjacent/Related Markets
5. Europe Direct-to-Consumer Laboratory Testing Market Assessment—by Application
5.1. Overview
5.2. Genetic Testing
5.2.1. Ancestry/Genealogy
5.2.2. Disease Risk Assessment
5.2.2.1. Cancer
5.2.2.2. Cardiovascular Diseases
5.2.2.3. Neurological Diseases
5.2.2.4. Other Diseases
5.2.3. Carrier Status
5.2.4. Other Genetic Tests
5.3. Diabetes Testing
5.4. Routine Clinical Testing
5.5. Thyroid Function Testing
5.6. COVID-19 Testing
5.7. Sexually Transmitted Disease Testing
5.8. Other Applications
6. Europe Direct-to-Consumer Laboratory Testing Market Assessment—by Sample Type
6.1. Overview
6.2. Blood
6.3. Saliva
6.4. Urine
6.5. Other Samples
7. Europe Direct-to-Consumer Laboratory Testing Market Assessment—by Country
7.1. Overview
7.2. U.K.
7.3. Germany
7.4. France
7.5. Spain
7.6. Italy
7.7. Switzerland
7.8. Netherlands
7.9. Belgium
7.10. Denmark
7.11. Ireland
7.12. Rest of Europe (RoE)
8. Competitive Analysis
8.1. Overview
8.2. Competitive Dashboard
8.2.1 Industry Leaders
8.2.2 Market Differentiators
8.2.3. Vanguards
8.2.4. Emerging Companies
8.3. Vendor Market Positioning
8.4. Market Share Analysis/Market Ranking (2022)
9. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis*)
9.1. LetsGetChecked, Inc. (U.S.)
9.2. Laboratoire CERBA (France)
9.3. 23andMe Holding Co. (U.S.)
9.4. Medichecks.com Ltd. (U.K.)
9.5. Cerascreen Biotech LLC (U.K.)
9.6. Living DNA Ltd (U.K.)
9.7. SelfDiagnostics Deutschland GmbH (Germany)
9.8. SYNLAB International GmbH (Germany)
9.9. Natrix S.r.l. (Italy)
9.10. Mainz Biomed Germany GmbH (Germany)
10. Appendix
10.1. Available Customization
10.2. Related Reports
List of Tables
Table 1 Europe Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 2 Europe Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 3 Europe Direct-to-consumer Genetic Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 4 Europe DTC Genetic Testing Market for Ancestry/Genealogy, by Country/Region, 2021–2030 (USD Million)
Table 5 Europe DTC Genetic Testing Market for Diseases Risk Assessment, by Type, 2021–2030 (USD Million)
Table 6 Europe DTC Genetic Testing Market for Diseases Risk Assessment, by Country/Region, 2021–2030 (USD Million)
Table 7 Europe Disease Risk Assessment Testing Market for Cancer, by Country/Region, 2021–2030 (USD Million)
Table 8 Europe Disease Risk Assessment Testing Market for Cardiovascular Diseases, by Country/Region, 2021–2030 (USD Million)
Table 9 Europe Disease Risk Assessment Testing Market for Neurological Diseases, by Country/Region, 2021–2030 (USD Million)
Table 10 Europe Disease Risk Assessment Testing Market for Other Diseases, by Country/Region, 2021–2030 (USD Million)
Table 11 Europe DTC Genetic Testing Market for Carrier Status, by Country/Region, 2021–2030 (USD Million)
Table 12 Europe DTC Genetic Testing Market for Other Genetic Tests, by Country/Region, 2021–2030 (USD Million)
Table 13 Europe DTC Diabetes Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Europe DTC Routine Clinical Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Europe DTC Thyroid Function Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Europe Direct-to-consumer Laboratory Testing Market for COVID-19 Testing, by Country/Region, 2021–2030 (USD Million)
Table 17 Europe Direct-to-consumer Laboratory Testing Market for Sexually Transmitted Diseases, by Country/Region, 2021–2030 (USD Million)
Table 18 Europe Direct-to-consumer Laboratory Testing Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 19 Europe Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 20 Europe Direct-to-consumer Laboratory Testing Market for Blood, by Country/Region, 2021–2030 (USD Million)
Table 21 Europe Direct-to-consumer Laboratory Testing Market for Saliva, by Country/Region, 2021–2030 (USD Million)
Table 22 Europe Direct-to-consumer Laboratory Testing Market for Urine, by Country/Region, 2021–2030 (USD Million)
Table 23 Europe Direct-to-consumer Laboratory Testing Market for Other Samples, by Country/Region, 2021–2030 (USD Million)
Table 24 Europe Direct-to-consumer Laboratory Testing Market, by Country/Region, 2021–2030 (USD Million)
Table 25 U.K.: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 26 U.K.: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 27 U.K.: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 28 U.K.: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 29 Germany: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 30 Germany: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 31 Germany: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 32 Germany: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 33 France: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 34 France: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 35 France: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 36 France: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 37 Spain: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 38 Spain: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 39 Spain: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 40 Spain: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 41 Italy: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 42 Italy: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 43 Italy: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 44 Italy: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 45 Switzerland: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 46 Switzerland: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 47 Switzerland: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 48 Switzerland: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 49 Netherlands: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 50 Netherlands: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 51 Netherlands: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 52 Netherlands: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 53 Belgium: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 54 Belgium: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 55 Belgium: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 56 Belgium: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 57 Denmark: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 58 Denmark: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 59 Denmark: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 60 Denmark: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 61 Ireland: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 62 Ireland: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 63 Ireland: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 64 Ireland: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 65 Rest of Europe: Direct-to-consumer Laboratory Testing Market, by Application, 2021–2030 (USD Million)
Table 66 Rest of Europe: Direct-to-consumer Genetic Testing Market, by Type, 2021–2030 (USD Million)
Table 67 Rest of Europe: Diseases Risk Assessment Market, by Type, 2021–2030 (USD Million)
Table 68 Rest of Europe: Direct-to-consumer Laboratory Testing Market, by Sample Type, 2021–2030 (USD Million)
Table 69 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for the Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Europe Direct-to-consumer Laboratory Testing Market Size, by Application, 2024 Vs. 2030 (USD Million)
Figure 8 Europe Direct-to-consumer Laboratory Testing Market Size, by Sample Type, 2024 Vs. 2030 (USD Million)
Figure 9 Direct-to-consumer Laboratory Testing Market, by Geography
Figure 10 Europe: Direct-to-consumer Laboratory Testing Market Snapshot
Figure 11 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 12 Competitive Dashboard: Direct-to-consumer Laboratory Testing Market
Figure 13 Direct-to-consumer Laboratory Testing Market: Vendor Benchmarking, by Application
Figure 14 Direct-to-consumer Laboratory Testing Market: Vendor Benchmarking, by Region
Figure 15 Europe Direct-to-consumer Laboratory Testing Market Share Analysis, by Key Players, 2022 (%)
Figure 16 23andMe Holding Co.: Financial Overview (2022)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Asia-Pacific DTC Laboratory Testing Market - Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jul-2024
Laboratory Mixers Market - Global Opportunity Analysis And Industry Forecast (2024-2030)
Published Date: Jun-2024
Genetic Testing Market - Global Opportunity Analysis And Industry Forecast (2023-2030)
Published Date: Apr-2023
